Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute pain management strategies in opioid substitution treatment
ACTRN12612000288820Phase 4Completed
- Sponsor
- Sydney Local Health District
- Start
- Mar 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methadone, buprenorphine, oxycodone and gabapentin in opioid use disorder (OUD) and acute pain (3 arms), sponsored by Sydney Local Health District. Primary endpoint: Change in pain threshold and tolerance using cold pressor model. Started Mar 2010; status: completed.
02
Drugs
methadonebuprenorphineoxycodonegabapentin
03
Conditions
opioid use disorder (OUD)acute pain
Beyond the preview
Go deeper on ACTRN12612000288820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000288820.